Doxazosin
- Product NDC
- 70934-366
- 11-digit product format
- 709340366
- Labeler code
- 70934
- Product ID
- 70934-366_afeb255e-78c8-1998-e053-2995a90a22e6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxazosin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA202824
- Marketing category
- ANDA
- Marketing start
- 2019-05-17
- Marketing end
- 0000-00-00
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 8 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70934-366-30 | Doxazosin | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70934-366 | DOXAZOSIN TABLET [DENTON PHARMA, INC. DBA NORTHWIND PHARMACEUTICALS] | 2 | Legacy NDC, 1 package rows | 20201224_8d40679a-d0cd-39b1-e053-2995a90a4085.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-366-30 | 70934036630 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-366-30) | 30 tablet | 2019-05-17 | 0000-00-00 | No | No | Current |